- Home
- PHAR vs NXJ Comparison
PHAR vs NXJ Comparison
Compare PHAR & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- NXJ
- Stock Information
- Founded
- PHAR 1988
- NXJ 1999
- Country
- PHAR Netherlands
- NXJ United States
- Employees
- PHAR N/A
- NXJ N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- NXJ Finance/Investors Services
- Sector
- PHAR Health Care
- NXJ Finance
- Exchange
- PHAR Nasdaq
- NXJ Nasdaq
- Market Cap
- PHAR 508.8M
- NXJ 520.4M
- IPO Year
- PHAR N/A
- NXJ N/A
- Fundamental
- Price
- PHAR $8.61
- NXJ $12.99
- Analyst Decision
- PHAR Strong Buy
- NXJ
- Analyst Count
- PHAR 1
- NXJ 0
- Target Price
- PHAR $37.00
- NXJ N/A
- AVG Volume (30 Days)
- PHAR 7.8K
- NXJ 74.9K
- Earning Date
- PHAR 10-24-2024
- NXJ 01-01-0001
- Dividend Yield
- PHAR N/A
- NXJ 3.27%
- EPS Growth
- PHAR N/A
- NXJ N/A
- EPS
- PHAR N/A
- NXJ N/A
- Revenue
- PHAR $277,557,000.00
- NXJ N/A
- Revenue This Year
- PHAR $21.91
- NXJ N/A
- Revenue Next Year
- PHAR $9.33
- NXJ N/A
- P/E Ratio
- PHAR N/A
- NXJ N/A
- Revenue Growth
- PHAR 34.54
- NXJ N/A
- 52 Week Low
- PHAR $6.65
- NXJ $10.06
- 52 Week High
- PHAR $13.20
- NXJ $12.24
- Technical
- Relative Strength Index (RSI)
- PHAR 56.47
- NXJ 55.19
- Support Level
- PHAR $8.22
- NXJ $12.94
- Resistance Level
- PHAR $9.09
- NXJ $13.03
- Average True Range (ATR)
- PHAR 0.43
- NXJ 0.08
- MACD
- PHAR 0.02
- NXJ -0.01
- Stochastic Oscillator
- PHAR 66.08
- NXJ 57.58
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.